Nam, H W
Karpyak, V M
Hinton, D J
Geske, J R
Ho, A M C
Prieto, M L
Biernacka, J M
Frye, M A
Weinshilboum, R M
Choi, D-S
Article History
Received: 4 March 2015
Revised: 4 June 2015
Accepted: 12 July 2015
First Online: 18 August 2015
Competing interests
: The medication (acamprosate) used in this study was in part provided by Forest Pharmaceuticals. Other than providing medication, neither Forest Pharmaceuticals nor its affiliates were involved in study conceptualization, design, data collection, data analysis, interpretation or preparation of the manuscript. Dr MAF has had grant support from Pfizer and Myriad, and has served as an unpaid consultant for Allergan, Myriad, Sunovion and Teva Pharmaceuticals. The remaining authors declare no conflict of interest.